Stock listing

Biocon Limited

Selected listing: BIOCON · BSE · INR · IN

Biocon Limited (BSE:BIOCON), Health Technology. Latest release Sep 21, 2026: Biocon Limited Press Release Sep 21 2026.

BIOCON:BSEINRINUpdated October 2, 2026
Biocon Limited logo
Ticker
BSE:BIOCON
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BSE
Currency
INR

About Biocon Limited

The company focuses on biopharmaceuticals and offers a range of products in areas such as diabetes, oncology, and autoimmune diseases. Biocon is committed to innovation and expanding access to affordable healthcare solutions.

Latest news from Biocon Limited

Biocon Limited Press Release Sep 21 2026

September 20, 2026

Biocon Limited Press Release Sep 08 2026

September 7, 2026

Biocon Announces Supplemental U.S. FDA Approval For Prefilled Autoinjector For YESINTEK

September 2, 2026

Biocon Launches Aflibercept Biosimilar In The United States

August 24, 2026

Biocon Limited Press Release Aug 05 2026

August 5, 2026

All Biocon Limited news →

Research Biocon Limited

Biocon Limited company profile

View the public company page for Biocon Limited on 6ix.

Biocon Limited news

Read company news and market updates connected to Biocon Limited.

Biocon Limited investor events

Find investor webinars, events, and replay context for Biocon Limited.

Alternate listings

BIOCON:NSE

IN · INR

Alternate listing for Biocon Limited; the primary context on this page is BIOCON:BSE.